Clement Meseko

Dr. Clement Meseko

Regional Centre for Animal Influenza, National Veterinary Research Institute, Vom 930010, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
AFAlice Fusaro
Alice Fusaro
BZBianca Zecchin
Bianca Zecchin
BVBram Vrancken
Bram Vrancken
CACelia Abolnik
Celia Abolnik
RARose Ademun
Rose Ademun
IMIsabella Monne
Isabella Monne
The role of Africa in the dynamics of the global spread of a zoonotic and economically-important virus, such as the highly pathogenic avian influenza (HPAI) H5Nx of the Gs/GD lineage, remains unexplored. Here we characterise the spatiotemporal patterns of virus diffusion during three HPAI H5Nx intercontinental epidemic waves and demonstrate that Africa mainly acted as an ecological sink of the HPAI H5Nx viruses. A joint analysis of host dynamics and continuous spatial diffusion indicates that poultry trade as well as wild bird migrations have contributed to the virus spreading into Africa, with West Africa acting as a crucial hotspot for virus introduction and dissemination into the continent. We demonstrate varying paths of avian influenza incursions into Africa as well as virus spread within Africa over time, which reveal that virus expansion is a complex phenomenon, shaped by an intricate interplay between avian host ecology, virus characteristics and environmental variables.

20 May 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
AOAkaninyene Otu
Akaninyene Otu
EEEmmanuel Effa
Emmanuel Effa
CMClement Meseko
Clement Meseko
SCSimeon Cadmus
Simeon Cadmus
COChinwe Ochu
Chinwe Ochu
BEBassey Ebenso
Bassey Ebenso

1 July 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
IMIsabella Monne
Isabella Monne
CMClement Meseko
Clement Meseko
TJTony Joannis
Tony Joannis
ISIsmaila Shittu
Ismaila Shittu
MAMohammed Ahmed
Mohammed Ahmed
GCGiovanni Cattoli
Giovanni Cattoli

12 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CMClement Meseko
Clement Meseko
AGAnja Globig
Anja Globig
JIJeremiah Ijomanta
Jeremiah Ijomanta
TJTony Joannis
Tony Joannis
CNChika Ignatius Nwosuh
Chika Ignatius Nwosuh
ESElke Starick
Elke Starick
Avian influenza viruses (AIV) potentially transmit to swine as shown by experiments, where further reassortment may contribute to the generation of pandemic strains. Associated risks of AIV inter-species transmission are greater in countries like Nigeria with recurrent epidemics of highly pathogenic AI (HPAI) in poultry and significant pig population. Analysis of 129 tracheal swab specimens collected from apparently healthy pigs at slaughterhouse during presence of HPAI virus H5N1 in poultry in Nigeria for influenza A by RT-qPCR yielded 43 positive samples. Twenty-two could be determined by clade specific RT-qPCR as belonging to the H5N1 clade 2.3.2.1c and confirmed by partial hemagglutinin (HA) sequence analysis. In addition, 500 swine sera were screened for antibodies against influenza A virus nucleoprotein and H5 HA using competition ELISAs and hemagglutination inhibition (HI) tests. Serologically, 222 (44.4%) and 42 (8.4%) sera were positive for influenza A virus NP and H5 antibodies, respectively. Sera reacted to H5N1 and A/H1N1pdm09 strains by HI suggesting exposure of the Nigerian domestic pig population to these viruses. We report for the first time in Nigeria, exposure of domestic pigs to H5N1 virus. This poses potential public health and pandemic risk due to interspecies transmission of avian and human influenza viruses.

29 November 2023 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
CMClement Meseko
Clement Meseko
MSMelvin Sanicas
Melvin Sanicas
KAKumari Asha
Kumari Asha
LSLanre Sulaiman
Lanre Sulaiman
BKBinod Kumar
Binod Kumar
Drugs and chemotherapeutics have helped to manage devastating impacts of infectious diseases since the concept of ‘magic bullet’. The World Health Organization estimates about 650,000 deaths due to respiratory diseases linked to seasonal influenza each year. Pandemic influenza, on the other hand, is the most feared health disaster and probably would have greater and immediate impact on humanity than climate change. While countermeasures, biosecurity and vaccination remain the most effective preventive strategies against this highly infectious and communicable disease, antivirals are nonetheless essential to mitigate clinical manifestations following infection and to reduce devastating complications and mortality. Continuous emergence of the novel strains of rapidly evolving influenza viruses, some of which are intractable, require new approaches towards influenza chemotherapeutics including optimization of existing anti-infectives and search for novel therapies. Effective management of influenza infections depend on the safety and efficacy of selected anti-infective in-vitro studies and their clinical applications. The outcomes of therapies are also dependent on understanding diversity in patient groups, co-morbidities, co-infections and combination therapies. In this extensive review, we have discussed the challenges of influenza epidemics and pandemics and discoursed the options for anti-viral chemotherapies for effective management of influenza virus infections.

23 May 2019 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
CWCatharine N. Welch
Catharine N. Welch
ISIsmaila Shittu
Ismaila Shittu
CACelia Abolnik
Celia Abolnik
PSPonman Solomon
Ponman Solomon
KDKiril M. Dimitrov
Kiril M. Dimitrov
Claudio AfonsoClaudio Afonso
Claudio Afonso